Hepatitis D Virus (HDV) is a viral infection that causes liver inflammation, sometimes leading to severe liver damage. It is caused by the HDV and is considered the most severe form of viral hepatitis in humans due to more rapid progression toward liver-related death and hepatocellular carcinoma. HDV requires hepatitis B virus (HBV) for its replication. HDV infection occurs as co-infection or as super-infection with HBV.
Simultaneous infection with HBV and HDV can lead to a mild-to-severe or even fulminant hepatitis, whereas the super-infection of HDV on chronic hepatitis B accelerates progression to more severe disease in all ages and 70‒90% of people.
Hepatitis D Virus Epidemiological Segmentation
The Epidemiological Segmentation of Hepatitis D Virus in 7MM from 2017 to 2030 is segmented as:-
Hepatitis D Virus Epidemiology
The therapeutic market of Hepatitis D Virus in 7MM in 2017 was USD 285.1 million.
Hepatitis D Virus Market Drivers
Hepatitis D Virus Market Barriers
Hepatitis D Virus Emerging Drugs
The Emerging Drugs of the Hepatitis D Virus market are
And many others.
And many others.
Hepatitis D Virus Key Players
The key players in the Hepatitis D Virus market are
And many others.